Document Detail

Effects of falipamil (AQ-A 39) on heart rate and blood pressure in resting and exercising healthy volunteers.
MedLine Citation:
PMID:  2475699     Owner:  NLM     Status:  MEDLINE    
Falipamil (AQ-A 39) is a new verapamil derivative which exerts antitachycardic effects by a direct action on the sinus node. Its effects on heart rate (HR), blood pressure (BP) and ECG intervals were studied in 12 healthy volunteers, at rest and during bicycle exercise tests. In a double-blind, cross-over, single-dose study, the effects of falipamil (100 and 200 mg) during 8-h post-dosing were compared with those of placebo. Falipamil did not modify resting HR, BP, and electrocardiogram (ECG) intervals significantly. Maximal exercise HR significantly decreased by 5.3 +/- 2.9 (SD)% and 11.2 +/- 3.6% 2 h after the 100- and 200-mg dose respectively, whereas placebo had no effect. Exercise BP was not significantly modified by falipamil. The slopes of HR-workload relationships significantly decreased with falipamil. Peak plasma concentrations of falipamil occurred 1-1.5 h after absorption, and the falipamil-induced decrease in exercise HR over 8 h postdosing was proportional to falipamil plasma concentrations. These results suggest that falipamil decreases HR at exercise in normal subjects and may exert antianginal effects in patients with myocardial ischemia.
M Naudascher; P Jaillon; B Lecocq; V Lecocq; A Ferry; J Hilaire; J F Maria
Related Documents :
17227959 - Long-term estrogen deficiency lowers regional blood flow, resting systolic blood pressu...
8589 - Electrodermal, cardiac, and respiratory activity to repeated cold pressor stimulation i...
18358779 - Cardiorespiratory responses during running and sport-specific exercises in handball pla...
3081979 - The reproducibility of the respiratory responses to maximum exercise.
8563679 - The time course for elevated muscle protein synthesis following heavy resistance exercise.
18972679 - Effect of salinity on the predatory performance of diplonychus rusticus (fabricius).
11905959 - Effects of alpha-tocopherol, beta-carotene and ascorbic acid on oxidative, hormonal and...
9001919 - Effect of 3 hours' passive smoke exposure in the evening on airway tone and responsiven...
8440859 - The atlanta ficsit study: two exercise interventions to reduce frailty in elders.
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  14     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1989 Jul 
Date Detail:
Created Date:  1989-10-04     Completed Date:  1989-10-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1-5     Citation Subset:  IM    
Unité de Pharmacologie Clinique, Hôpital Saint-Antoine, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Pressure / drug effects*
Cardiovascular Agents / adverse effects,  pharmacokinetics,  pharmacology*
Double-Blind Method
Heart Rate / drug effects*
Phthalimides / adverse effects,  pharmacokinetics,  pharmacology*
Reg. No./Substance:
0/Cardiovascular Agents; 0/Isoindoles; 0/Phthalimides; 77862-92-1/falipamil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Development of hypertension and life span in stroke-prone spontaneously hypertensive rats during ora...
Next Document:  Effects of the novel beta-adrenergic partial agonist alifedrine on cardiac performance in dogs with ...